Home > Insider Trading > Filing (0001062993-21-011704)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1828522	Effector Therapeutics Inc.	EFTR	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1440514	Us Venture Partners X Lp	1460 El Camino Real, Ste 100 Menlo Park CA 94025	No	No	Yes	No
1453359	Usvp X Affiliates Lp	1460 El Camino Real, Ste 100 Menlo Park CA 94025	No	No	Yes	No
1474322	M Casey Tansey	1460 El Camino Real Suite 100 Menlo Park CA 94025	No	No	Yes	No
1602744	Presidio Management Group X Llc	1460 El Camino Real, Ste 100 Menlo Park CA 94025	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-11-23	14,418	$7.40	4,502,592	No	4	S	Indirect	Directly owned by USVP X
Common Stock	Disposition	2021-11-23	461	$7.40	144,047	No	4	S	Indirect	Directly owned by AFF X
Common Stock	Disposition	2021-11-24	35,388	$7.36	4,467,204	No	4	S	Indirect	Directly owned by USVP X
Common Stock	Disposition	2021-11-24	1,132	$7.36	142,915	No	4	S	Indirect	Directly owned by AFF X
Common Stock	Disposition	2021-11-26	4,870	$7.01	4,462,334	No	4	S	Indirect	Directly owned by USVP X
Common Stock	Disposition	2021-11-26	156	$7.01	142,759	No	4	S	Indirect	Directly owned by AFF X

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Directly owned by USVP X
No	4	S	Indirect	Directly owned by AFF X
No	4	S	Indirect	Directly owned by USVP X
No	4	S	Indirect	Directly owned by AFF X
No	4	S	Indirect	Directly owned by USVP X
No	4	S	Indirect	Directly owned by AFF X

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.33 to $7.63, inclusive for sales on 11/23/21; prices ranging from $7.25 to $7.48, inclusive for sales on 11/24/21; prices ranging from $6.75 to $7.34, inclusive for sales on 11/26/21. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
Presidio Management Group X, L.L.C. ("PMG X"), the general partner of each of U.S. Venture Partners X, L.P. ("USVP X") and USVP X Affiliates L.P. ("AFF X") (together, the "USVP X Funds"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein.